MRI-compatible device developer Biophan Technologies of Rochester, NY, received funding and equipment support from two sources to help advance its technologies.
Biophan was awarded $1 million from the 2007 U.S. Department of Defense appropriations bill to develop its Myotech MYO-VAD minimally invasive cardiac-assist device, designed to increase survival rates of patients suffering from heart failure.
In addition, the New York State Office of Science, Technology and Academic Research sent the firm $309,000 in equipment for nanomagnetic particle R&D in both MRI imaging and drug delivery.
By AuntMinnie.com staff writers
June 30, 2006
Related Reading
Biophan restructures board, June 15, 2006
Biophan nets financing, May 19, 2006
Biophan adds to advisory board, May 18, 2006
Biophan inks R&D deal with FDA, May 3, 2006
Biophan makes executive moves, April 12, 2006
Copyright © 2006 AuntMinnie.com
